Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Modeling SARS-CoV-2 in mice: Among the research tools necessary to develop medical interventions to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, high on the list are informative animal models with which to study viral pathogenesis. Gu et al. developed a mouse model in which a SARS-CoV-2 strain was infectious and could cause an inflammatory response and moderate pneumonia. Adaptation of this viral strain in the mouse appeared to be dependent on a critical amino acid change, Asn 501 to Tyr (N501Y), within the receptor-binding domain of the viral spike protein. The new mouse model was used to study neutralizing antibodies and a vaccine candidate against the virus. Science , this issue p. 1603
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although mouse models have the most information available about their biology and many research tools, the ACE2 receptor is significantly different between mice and humans; so mouse models most often use a humanized ACE2 or lung passage to overcome this obstacle. 177-179”
From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [179]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Self-citationA novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Self-citationA pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Self-citationDipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
Raj, V. S., Mou, H., Smits, S. L., Dekkers, D. H. W., Müller, M. A., Dijkman, R., Muth, D., Demmers, J. A. A., Zaki, A., Fouchier, R. A. M., et al. (2013) · Nature · doi:10.1038/nature12005 · Cited by 2,061
Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2
Shi, J., Wen, Z., Zhong, G., Yang, H., Wang, C., Huang, B., Liu, R., He, X., Shuai, L., Sun, Z., et al. (2020) · Science · doi:10.1126/science.abb7015 · Cited by 1,911
The spike protein of SARS-CoV — a target for vaccine and therapeutic development
Du, L., He, Y., Zhou, Y., Liu, S., Zheng, B.-J., & Jiang, S. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2090 · Cited by 1,661
Self-citationTai, W., He, L., Zhang, X., Pu, J., Voronin, D., Jiang, S., Zhou, Y., & Du, L. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0400-4 · Cited by 1,654
Self-citationImmunology of COVID-19: Current State of the Science
Vabret, N., Britton, G. J., Gruber, C., Hegde, S., Kim, J., Kuksin, M., Levantovsky, R., Malle, L., Moreira, A., Park, M. D., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.002 · Cited by 1,623
Self-citationDevelopment of an inactivated vaccine candidate for SARS-CoV-2
Gao, Q., Bao, L., Mao, H., Wang, L., Xu, K., Yang, M., Li, Y., Zhu, L., Wang, N., Lv, Z., et al. (2020) · Science · doi:10.1126/science.abc1932 · Cited by 1,434
Self-citationCarsana, L., Sonzogni, A., Nasr, A., Rossi, R. S., Pellegrinelli, A., Zerbi, P., Rech, R., Colombo, R., Antinori, S., Corbellino, M., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30434-5 · Cited by 1,396
Cited by
Items 301–400 of 786
Renn, M., Bartok, E., Zillinger, T., Hartmann, G., & Behrendt, R. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107931 · Cited by 30
Meta-Analysis and Structural Dynamics of the Emergence of Genetic Variants of SARS-CoV-2
Castonguay, N., Zhang, W., & Langlois, M. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.676314 · Cited by 29
Murugan, C., Ramamoorthy, S., Kuppuswamy, G. P., Murugan, R. K., Sivalingam, Y., & Sundaramurthy, A. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.10.144 · Cited by 31
LRRC15 inhibits SARS-CoV-2 cellular entry in trans
Song, J., Chow, R. D.-W., Peña-Hernández, M. A., Zhang, L., Loeb, S. A., So, E. Y., Liang, O. D., Ren, P., Chen, S., Wilen, C. B., et al. (2022) · PLoS Biology · doi:10.1371/journal.pbio.3001805 · Cited by 32
Self-citationMouse models of COVID-19 recapitulate inflammatory pathways rather than gene expression
Bishop, C., Dumenil, T. D., Rawle, D. J., Le, T. T., Yan, K., Tang, B., Härtel, G., & Suhrbier, A. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010867 · Cited by 31
Graham, C., Seow, J., Huettner, I., Khan, H., Kouphou, N., Acors, S., Winstone, H., Pickering, S., Galao, R. P., Lista, M. J., et al. (2021) · doi:10.1101/2021.02.03.429355 · Cited by 27
Insights into SARS-CoV-2 evolution, potential antivirals, and vaccines
Abdel-Moneim, A. S., Abdelwhab, E. M., & Memish, Z. A. (2021) · Virology · doi:10.1016/j.virol.2021.02.007 · Cited by 29
Molecular-Level Anatomy of SARS-CoV-2 for the Battle against the COVID-19 Pandemic
Komiyama, M. (2021) · Bulletin of the Chemical Society of Japan · doi:10.1246/bcsj.20210030 · Cited by 27
The Mechanisms and Animal Models of SARS-CoV-2 Infection
Jia, W., Wang, J., Sun, B., Zhou, J., Shi, Y., & Zhou, Z. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.578825 · Cited by 29
SARS-CoV-2 Infection: Host Response, Immunity, and Therapeutic Targets
Shivshankar, P., Karmouty‐Quintana, H., Mills, T., Doursout, M., Wang, Y., Czopik, A. K., Evans, S. E., Eltzschig, H. K., & Yuan, X. (2022) · Inflammation · doi:10.1007/s10753-022-01656-7 · Cited by 30
Self-citationMitsui, Y., Suzuki, T., Kuniyoshi, K., Inamo, J., Yamaguchi, K., Komuro, M., Watanabe, J., Edamoto, M., Li, S., Kouno, T., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.06.013 · Cited by 27
Dutta, T., Baildya, N., Khan, A. A., & Ghosh, N. N. (2021) · Network Modeling Analysis in Health Informatics and Bioinformatics · doi:10.1007/s13721-021-00309-3 · Cited by 27
Younes, S. N., Younes, N., Shurrab, F. M., & Nasrallah, G. K. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2196 · Cited by 27
Bridging animal and clinical research during SARS-CoV-2 pandemic: A new-old challenge
Winkler, M. S., Skirecki, T., Brunkhorst, F. M., Cajander, S., Cavaillon, J., Ferrer, R., Flohé, S. B., García‐Salido, A., Giamarellos‐Bourboulis, E. J., Girardis, M., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103291 · Cited by 26
Liu, Z., Wu, H., Egland, K. A., Gilliland, T. C., Dunn, M. D., Luke, T. C., Sullivan, E. J., Klimstra, W. B., Bausch, C. L., & Whelan, S. P. J. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.1940652 · Cited by 26
Rattanapisit, K., Bulaon, C. J. I., Khorattanakulchai, N., Shanmugaraj, B., Wangkanont, K., & Phoolcharoen, W. (2021) · PLoS ONE · doi:10.1371/journal.pone.0253574 · Cited by 26
Mouse models in COVID-19 research: analyzing the adaptive immune response
Clever, S., & Volz, A. (2022) · Medical Microbiology and Immunology · doi:10.1007/s00430-022-00735-8 · Cited by 27
The Spike Protein of SARS-CoV-2 Is Adapting Because of Selective Pressures
López-Cortés, G. I., Palacios-Pérez, M., Veledíaz, H. F., Hernández-Aguilar, M. M., López-Hernández, G. R., Zamudio, G. S., & José, M. V. (2022) · Vaccines · doi:10.3390/vaccines10060864 · Cited by 28
Effect of polymorphism in Rhinolophus affinis ACE2 on entry of SARS-CoV-2 related bat coronaviruses
Li, P. S., Hu, J., Liu, Y., Ou, X., Mu, Z., Xing, L., Zan, F., Cao, M., Tan, L., Dong, S., et al. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011116 · Cited by 27
Self-citationZareie, A. R., Dabral, P., & Verma, S. C. (2024) · Pathogens · doi:10.3390/pathogens13010060 · Cited by 26
Potential SARS-CoV-2 vaccines: Concept, progress, and challenges
Hosseini, S. A., Zahedipour, F., Mirzaei, H., & Oskuee, R. K. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107622 · Cited by 28
Surveillance of Rodent Pests for SARS-CoV-2 and Other Coronaviruses, Hong Kong
Miot, E. F., Worthington, B. M., Ng, K. H., de Lataillade, L. D. G., Pierce, M. P., Liao, Y., Ko, R. L., Shum, M. H.-H., Cheung, W. Y., Holmes, E. C., et al. (2022) · Emerging infectious diseases · doi:10.3201/eid2802.211586 · Cited by 26
Tada, T., Zhou, H., Dcosta, B. M., Samanovic, M. I., Cornelius, A. R., Herati, R. S., Mulligan, M. J., & Landau, N. R. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110237 · Cited by 25
Shalash, A. O., Hussein, W. M., Skwarczyński, M., & Tóth, I. (2021) · Advanced Science · doi:10.1002/advs.202100985 · Cited by 28
Evolution, correlation, structural impact and dynamics of emerging SARS-CoV-2 variants
Spratt, A. N., Kannan, S. R., Woods, L. T., Weisman, G. A., Quinn, T. P., Lorson, C. L., Sönnerborg, A. B., Byrareddy, S. N., & Singh, K. D. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.06.037 · Cited by 25
Expression pattern and function of SARS-CoV-2 receptor ACE2
Li, R.-T., & Qin, C. (2021) · Biosafety and Health · doi:10.1016/j.bsheal.2021.08.003 · Cited by 27
Self-citationFunctional Effects of Receptor-Binding Domain Mutations of SARS-CoV-2 B.1.351 and P.1 Variants
Bayarri‐Olmos, R., Jarlhelt, I., Johnsen, L. B., Hansen, C. B., Helgstrand, C., Bjelke, J. R., Matthiesen, F., Nielsen, S. D., Iversen, K. K., Ostrowski, S. R., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.757197 · Cited by 28
Rapid test to assess the escape of SARS-CoV-2 variants of concern
Heggestad, J. T., Britton, R. J., Kinnamon, D., Wall, S. A., Joh, D. Y., Hucknall, A., Olson, L. B., Anderson, J. G., Mazur, A., Wolfe, C. R., et al. (2021) · Science Advances · doi:10.1126/sciadv.abl7682 · Cited by 26
Rabaan, A. A., Al-Ahmed, S. H., Albayat, H., Alwarthan, S. M., Alhajri, M. M., Najim, M. A., Alshehail, B. M., Al-Adsani, W., Alghadeer, A., Abduljabbar, W. A., et al. (2023) · Medicina · doi:10.3390/medicina59030507 · Cited by 29
The ecology of viruses in urban rodents with a focus on SARS-CoV-2
Fisher, A. M., Airey, G., Liu, Y., Gemmell, M., Thomas, J., Bentley, E. G., Whitehead, M., Paxton, W. A., Pollakis, G., Paterson, S., et al. (2023) · Emerging Microbes & Infections · doi:10.1080/22221751.2023.2217940 · Cited by 27
LY6E is a pan-coronavirus restriction factor in the respiratory tract
Mar, K. B., Wells, A. I., Dyke, M. C. C. V., Lopez, A. H., Eitson, J. L., Fan, W., Hanners, N. W., Evers, B. M., Shelton, J. M., & Schoggins, J. W. (2023) · Nature Microbiology · doi:10.1038/s41564-023-01431-w · Cited by 26
SARS-CoV-2 variants of concern alpha, beta, gamma and delta have extended ACE2 receptor host ranges
Thakur, N., Gallo, G., Newman, J., Peacock, T. P., Biasetti, L., Hall, C. N., Wright, E., Barclay, W., & Bailey, D. (2022) · Journal of General Virology · doi:10.1099/jgv.0.001735 · Cited by 25
Cell and Animal Models for SARS-CoV-2 Research
Bestion, E., Halfon, P., Mezouar, S., & Mège, J. (2022) · Viruses · doi:10.3390/v14071507 · Cited by 26
Sharma, S., Vercruysse, T., Sánchez-Felipe, L., Kerstens, W., Rasulova, M., Bervoets, L., Keyzer, C. D., Abdelnabi, R., Foo, C. S.-Y., Lemmens, V., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34439-7 · Cited by 27
SARS‐CoV‐2‐related bat virus behavior in human‐relevant models sheds light on the origin of COVID‐19
Temmam, S., Montagutelli, X., Hérate, C., Donati, F., Regnault, B., Attia, M., Baquero, E., Chrétien, D., Conquet, L., Jouvion, G., et al. (2023) · EMBO Reports · doi:10.15252/embr.202256055 · Cited by 26
Research progress in spike mutations of SARS‐CoV‐2 variants and vaccine development
He, X., He, C., Hong, W., Yang, H. J., & Wei, X. (2023) · Medicinal Research Reviews · doi:10.1002/med.21941 · Cited by 28
Zhang, Y., Sun, J., Zheng, J. H., Li, S., Rao, H., Dai, J., Zhang, Z., Wang, Y., Liu, D., Chen, Z., et al. (2023) · Advanced Science · doi:10.1002/advs.202303366 · Cited by 26
Self-citationZhang, Y.-N., Li, X., Zhang, Z.-R., Zhang, H.-Q., Liu, J., Li, J., Li, J., Wang, Z.-J., Wang, Z.-J., Shen, S., et al. (2020) · Cell Research · doi:10.1038/s41422-020-00405-5 · Cited by 24
Self-citationThe Antigenicity of Epidemic SARS-CoV-2 Variants in the United Kingdom
Wu, J., Zhang, L., Zhang, Y., Wang, H., Ding, R., Nie, J., Li, Q., Liu, S., Yu, Y., Yang, X., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.687869 · Cited by 23
Self-citationBinding affinity and mechanisms of SARS-CoV-2 variants
Han, Y., Wang, Z., Wei, Z., Schapiro, I., & Li, J. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.07.026 · Cited by 25
Self-citationZayani, R., Rezig, D., Farès, W., Marrakchi, M., Essafi, M., & Raouafi, N. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c01950 · Cited by 23
Infection with the SARS-CoV-2 B.1.351 variant is lethal in aged BALB/c mice
Yasui, F., Matsumoto, Y., Yamamoto, N., Sanada, T., Honda, T., Munakata, T., Itoh, Y., & Kohara, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-08104-4 · Cited by 23
Insights from Transcriptomics: CD163+ Profibrotic Lung Macrophages in COVID-19
Bhattacharya, M. (2022) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2022-0107tr · Cited by 26
Immunogenic properties of SARS-CoV-2 inactivated by ultraviolet light
Gracheva, A. V., Korchevaya, E. R., Ammour, Y. I., Smirnova, D. I., Sokolova, O. S., Glukhov, G. S., Moiseenko, A. V., Zubarev, I. V., Samoilikov, R. V., Leneva, I. A., et al. (2022) · Archives of Virology · doi:10.1007/s00705-022-05530-7 · Cited by 23
Interferons—Implications in the Immune Response to Respiratory Viruses
Bergeron, H. C., Hansen, M. R., & Tripp, R. A. (2023) · Microorganisms · doi:10.3390/microorganisms11092179 · Cited by 26
2-thiouridine is a broad-spectrum antiviral nucleoside analogue against positive-strand RNA viruses
Uemura, K., Nobori, H., Sato, A., Toba, S., Kusakabe, S., Sasaki, M., Tabata, K., Matsuno, K., Maeda, N., Ito, S., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2304139120 · Cited by 25
Lam, S. D., Bordin, N., Waman, V., Scholes, H., Ashford, P., Sen, N., van Dorp, L., Rauer, C., Dawson, N., Pang, C., et al. (2020) · UCL Discovery (University College London) · Cited by 23
Picazo, J. J. (2021) · Revista Española de Quimioterapia · doi:10.37201/req/085.2021 · Cited by 31
Hok, L., Rimac, H., Mavri, J., & Vianello, R. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.02.020 · Cited by 26
SARS-CoV-2-specific immunoglobulin Y antibodies are protective in infected mice
El-Kafrawy, S. A., Odle, A. E., Abbas, A. T., Hassan, A. M., Abdel-dayem, U. A., Qureshi, A. K., Wong, L.-Y. R., Zheng, J. H., Meyerholz, D. K., Perlman, S. M., et al. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010782 · Cited by 22
Thieulent, C., Dittmar, W., Balasuriya, U. B. R., Crossland, N. A., Wen, X., Richt, J. A., & Carossino, M. (2023) · mSphere · doi:10.1128/msphere.00558-22 · Cited by 22
Tillgren, S. M., Nieto‐Fontarigo, J. J., Cerps, S., Ramu, S., Menzel, M., Persson, I. M., Meißner, A., Akbarshahi, H., & Uller, L. (2023) · Journal of Inflammation · doi:10.1186/s12950-023-00331-4 · Cited by 22
Li, X., Xu, M., Yang, J., Zhou, L., Liu, L., Li, M., Wang, S., Liu, M., Huang, Z., Zhang, Z., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01822-3 · Cited by 23
Self-citationTransmission of SARS-CoV-2 in domestic cats imposes a narrow bottleneckPreprint
Braun, K. M., Moreno, G. K., Halfmann, P., Hodcroft, E. B., Baker, D. A., Boehm, E. C., Weiler, A. M., Haj, A. K., Hatta, M., Chiba, S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.16.384917 · Cited by 23
Tamoxifen and clomiphene inhibit SARS-CoV-2 infection by suppressing viral entry
Zu, S., Luo, D., Li, L., Ye, Q., Li, R.-T., Wang, Y., Gao, M., Yang, H., Deng, Y., & Cheng, G. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00853-4 · Cited by 22
Self-citationBruter, A. V., Korshunova, D. S., Kubekina, M. V., Владимирович, С. П., Kalinina, A. A., Ilchuk, L. A., Silaeva, Y. Y., Korshunov, E. N., Soldatov, V. O., & Deykin, A. V. (2021) · Transgenic Research · doi:10.1007/s11248-021-00249-8 · Cited by 23
On the origin of SARS-CoV-2—The blind watchmaker argument
Wu, C., Wen, H., Lü, J., Su, X., Hughes, A. C., Zhai, W., Chen, C., Chen, H., Li, M., Song, S., et al. (2021) · Science China Life Sciences · doi:10.1007/s11427-021-1972-1 · Cited by 21
Self-citationTransient acquisition of cross-species infectivity during the evolution of SARS-CoV-2
Chen, Q., Huang, X., Sun, M., Li, R.-T., Gu, H., Tian, Y., Zhang, R., Luo, D., Chao Hui, Z. H. O. U., Zhang, Y., et al. (2021) · National Science Review · doi:10.1093/nsr/nwab167 · Cited by 21
Self-citationGómez, S. A., Rojas‐Valencia, N., Gómez, S., Cappelli, C., & Restrepo, A. A. (2021) · ChemBioChem · doi:10.1002/cbic.202100393 · Cited by 22
Wang, Q., Ye, S., Zhou, Z., Li, J., Lv, J., Hu, B., Yuan, S., Qiu, Y., & Ge, X. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28116 · Cited by 23
Self-citationBiparatopic nanobodies targeting the receptor binding domain efficiently neutralize SARS-CoV-2
Pymm, P., Redmond, S. J., Dolezal, O., Mordant, F. L., López, E., Cooney, J. P., Davidson, K. C., Haycroft, E. R., Tan, C. W., Seneviratna, R., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105259 · Cited by 21
Phenothiazines inhibit SARS-CoV-2 cell entry via a blockade of spike protein binding to neuropilin-1
Hashizume, M., Takashima, A., Ono, C., Okamoto, T., & Iwasaki, M. (2022) · Antiviral Research · doi:10.1016/j.antiviral.2022.105481 · Cited by 23
A novel metaheuristic algorithm inspired by COVID-19 for real-parameter optimization
Mohammadi, S. K., Nazarpour, D., & Beiraghi, M. (2023) · Neural Computing and Applications · doi:10.1007/s00521-023-08229-1 · Cited by 24
Animal models to study the neurological manifestations of the post-COVID-19 condition
Usai, C., Mateu, L., Brander, C., Vergara‐Alert, J., & Segalés, J. (2023) · Lab Animal · doi:10.1038/s41684-023-01231-z · Cited by 24
Experimental Animal Models of Coronavirus Infections: Strengths and Limitations
Casel, M. A. B., Rollon, R., & Choi, Y. K. (2021) · Immune Network · doi:10.4110/in.2021.21.e12 · Cited by 22
Animal Models of COVID-19 II. Comparative Immunology
Veenhuis, R. T., & Zeiss, C. J. (2021) · ILAR Journal · doi:10.1093/ilar/ilab010 · Cited by 22
Alves, J., Engel, L., Cabral, R. D. V., Rodrigues, E. L., Ribeiro, L. D. J., Higa, L. M., Júnior, O. D. C. F., Castiñeiras, T. M. P. P., Leitão, I. D. C., Tanuri, A., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-97330-3 · Cited by 23
Molecular variants of SARS-CoV-2: antigenic properties and current vaccine efficacy
Damavandi, A. R., Dowran, R., Sharif, S. A., Kashanchi, F., & Jafari, R. (2022) · Medical Microbiology and Immunology · doi:10.1007/s00430-022-00729-6 · Cited by 23
Effect of SARS-CoV-2 spike mutations on animal ACE2 usage and in vitro neutralization sensitivityPreprint
Yao, W., Ma, D., Wang, H., Tang, X., Du, C., Pan, H., Li, C., Lin, H., Farzan, M., Zhao, J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.27.428353 · Cited by 22
Self-citationSARS-CoV-2 spillover transmission due to recombination event
Shahhosseini, N., Wong, G., Kobinger, G., & Chinikar, S. (2021) · Gene Reports · doi:10.1016/j.genrep.2021.101045 · Cited by 21
Comparative characterization of SARS‐CoV‐2 variants of concern and mouse‐adapted strains in mice
Chen, Q., Huang, X., Liu, Y., Sun, M., Ji, B., Chao Hui, Z. H. O. U., Chi, H., Zhang, R., Luo, D., Tian, Y., et al. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27735 · Cited by 21
Self-citationZhang, Z., Zhou, L., Liu, Q., Zheng, Y., Tan, X., Huang, Z., Guo, M. S., Wang, X., Chen, X., Liang, S., et al. (2024) · Emerging Microbes & Infections · doi:10.1080/22221751.2024.2353302 · Cited by 21
Self-citationInsights into coronavirus immunity taught by the murine coronavirus
Grabherr, S., Ludewig, B., & Pikor, N. B. (2021) · European Journal of Immunology · doi:10.1002/eji.202048984 · Cited by 23
Animal Hosts and Experimental Models of SARS-CoV-2 Infection
Parolin, C., Virtuoso, S., Giovanetti, M., Angeletti, S., Ciccozzi, M., & Borsetti, A. (2021) · Chemotherapy · doi:10.1159/000515341 · Cited by 21
van de Leemput, J., & Han, Z. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00621-5 · Cited by 22
Animal models for SARS-CoV-2 and SARS-CoV-1 pathogenesis, transmission and therapeutic evaluation
Saravanan, U. B., Namachivayam, M., Jeewon, R., Huang, J., & Durairajan, S. S. K. (2022) · World Journal of Virology · doi:10.5501/wjv.v11.i1.40 · Cited by 21
Courjon, J., Contenti, J., Demonchy, É., Levraut, J., Barbry, P., Rios, G., Dellamonica, J., Chirio, D., Bonnefoy, C., Giordanengo, V., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-95067-7 · Cited by 19
Yang, M., Li, J., Huang, Z., Li, H., Wang, Y., Wang, X., Kang, S., Huang, X., Wu, C., Liu, T., et al. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.01352-21 · Cited by 21
Self-citationWang, B., Goh, Y. S., Prince, T., Ngoh, E. Z. X., Salleh, S. N. M., Hor, P. X., Loh, C. Y., Fong, S., Hartley, C. S., Tan, S. Y., et al. (2021) · npj Vaccines · doi:10.1038/s41541-021-00389-2 · Cited by 21
Antibody cocktail effective against variants of SARS-CoV-2
Liang, K.-H., Chiang, P.-Y., Ko, S.-H., Chou, Y., Lu, R., Lin, H.-T., Wy, C., Lin, Y., Tao, M., Jan, J., et al. (2021) · Journal of Biomedical Science · doi:10.1186/s12929-021-00777-9 · Cited by 20
Sex-dependent immune response and lethality of COVID-19
Li, A. J., & Li, X. (2020) · Stem Cell Research · doi:10.1016/j.scr.2020.102116 · Cited by 23
Self-citationSARS-CoV-2 variants lacking ORF8 occurred in farmed mink and pangolin
Pereira, F. (2021) · Gene · doi:10.1016/j.gene.2021.145596 · Cited by 19
Host parameters and mode of infection influence outcome in SARS-CoV-2-infected hamsters
Griffin, B. D., Warner, B. M., Chan, M., Valcourt, E. J., Tailor, N., Banadyga, L., Leung, A., He, S., Boese, A. S., Audet, J., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103530 · Cited by 19
Deng, Y., Li, J., Sun, C., Chi, H., Luo, D., Wang, R., Qiu, H., Zhang, Y., Wu, M. L., Zhang, X., et al. (2022) · Advanced Materials · doi:10.1002/adma.202200443 · Cited by 26
Self-citationTyrkalska, S. D., Candel, S., Pedoto, A., García‐Moreno, D., Alcaraz‐Pérez, F., Sánchez‐Ferrer, Á., Cayuela, M. L., & Mulero, V. (2022) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuac042 · Cited by 20
Evolution of Immune Evasion and Host Range Expansion by the SARS-CoV-2 B.1.1.529 (Omicron) Variant
Ren, W., Zhang, Y., Rao, J., Wang, Z., Lan, J., Liu, K., Zhang, X., Hu, X., Yang, C., Zhong, G., et al. (2023) · mBio · doi:10.1128/mbio.00416-23 · Cited by 24
Self-citationSevere Acute Respiratory Syndrome Type 2‐Causing Coronavirus: Variants and Preventive Strategies
Aydoğdu, M. O., Rohn, J. L., Jafari, N. V., Brako, F., Homer‐Vanniasinkam, S., & Edirisinghe, M. J. (2022) · Advanced Science · doi:10.1002/advs.202104495 · Cited by 20
Comparative susceptibility of SARS-CoV-2, SARS-CoV, and MERS-CoV across mammals
Li, M., Du, J., Liu, W., Li, Z., Lv, F., Hu, C., Dai, Y., Zhang, X., Zhang, Z., Liu, G., et al. (2023) · The ISME Journal · doi:10.1038/s41396-023-01368-2 · Cited by 22
Self-citationCase, J. B., Sanapala, S., Dillen, C. A., Rhodes, V., Zmasek, C. M., Chicz, T. M., Switzer, C., Scheaffer, S. M., Georgiev, G. P., Jacob-Dolan, C., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.10.016 · Cited by 20
Berguer, P. M., Blaustein, M., Bredeston, L. M., Craig, P. O., D’Alessio, C., Elias, F., Farré, P. C., Fernández, N., Gentili, H., Gándola, Y. B., et al. (2022) · Scientific Reports · doi:10.1038/s41598-021-03675-0 · Cited by 28
Animal Models of COVID-19: Transgenic Mouse Model
Park, J., Pino, P. A., Akhter, A., Alvarez, X. A., Torrelles, J. B., & Martínez‐Sobrido, L. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2111-0_16 · Cited by 19
Comparative phylogenetic analysis of SARS-CoV-2 spike protein—possibility effect on virus spillover
Ghorbani, A., Samarfard, S., Eskandarzade, N., Afsharifar, A., Eskandari, M. H., Niazi, A., Izadpanah, K., & Karbanowicz, T. P. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab144 · Cited by 18
Perez-Romero, C. A., Tonda, A. P., Mendoza‐Maldonado, L., Coz, E., Tabeling, P., Vanhomwegen, J., Claassen, E., Garssen, J., Kraneveld, A. D., & Lopez‐Rincon, A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.20.427043 · Cited by 23
Watashi, K. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.10.094 · Cited by 17
Hamdy, M. E., El‐Deeb, A. H., Hagag, N. M., Shahein, M. A., Alaidi, O., & Hussein, H. A. (2023) · International Journal of Veterinary Science and Medicine · doi:10.1080/23144599.2023.2222981 · Cited by 21
COVID‐19: An Overview of SARS‐CoV‐2 Variants—The Current Vaccines and Drug Development
Bostanghadiri, N., Ziaeefar, P., Mofrad, M. G., Yousefzadeh, P., Hashemi, A., & Darban‐Sarokhalil, D. (2023) · BioMed Research International · doi:10.1155/2023/1879554 · Cited by 18
Captopril alleviates lung inflammation in SARS-CoV-2-infected hypertensive mice
Gao, W., 650500,中国, 昆. 昆., Ma, X., Wang, P., He, X.-Y., Zheng, Y., Liu, F., Zheng, C., 650223,中国, 中. 昆., & 650107,中国, 中. 昆. (2021) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2021.206 · Cited by 17
Thakur, N. N., Das, S., Kumar, S., Maurya, V. K., Dhama, K., Paweska, J. T., Abdel-Moneim, A. S., Jain, A., Tripathi, A. K., Puri, B., et al. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28060 · Cited by 21
Wang, Y., Zhou, Z., Wu, X., Li, T., Wu, J., Cai, M., Nie, J., Wang, W., & Cui, Z. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-99-0113-5_1 · Cited by 18
Self-citationChen, Y., Li, S., Wu, W., Geng, S., & Mao, M. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27580 · Cited by 18
Self-citation
Metadata
- Authors
- Gu, H., Chen, Q., Yang, G., He, L., Fan, H., Deng, Y.-Q., Wang, Y., Teng, Y., Zhao, Z., Cui, Y., Li, Y., Li, X.-F., Li, J., Zhang, N.-N., Yang, X., Chen, S., Guo, Y., Zhao, G., Wang, X., Luo, D.-Y., Wang, H., Yang, X., Li, Y., Han, G., He, Y., Zhou, X., Geng, S., Sheng, X., Jiang, S., Sun, S., Qin, C.-F., & Zhou, Y.
- Affiliations
- Academy of Military Medical Sciences (CN)
- Beijing Proteome Research Center (CN)
- State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China.
- Institute of Military Cognition and Brain Sciences, Beijing 100850, China.
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Beijing JOINN Biologics Co., Beijing 100176, China.
- Shanghai Medical College of Fudan University (CN)
- Corresponding author
- Gu, Hongjing
- Chen, Qi
- Yang, Guan
- He, Lei
- Fan, Hang
- Deng, Yong-Qiang
- Jiang, Shibo
- Sun, Shihui
- Qin, Cheng-Feng
- Zhou, Yusen
- ORCID
- Gu, Hongjing
- Chen, Qi
- Yang, Guan
- He, Lei
- Fan, Hang
- Deng, Yong-Qiang
- Wang, Yanxiao
- Teng, Yue
- Zhao, Zhongpeng
- Cui, Yujun
- Li, Yuchang
- Li, Xiao-Feng
- Li, Jiangfan
- Zhang, Na-Na
- Yang, Xiaolan
- Chen, Shaolong
- Guo, Yan
- Zhao, Guangyu
- Wang, Xiliang
- Wang, Hui
- Yang, Xiao
- Li, Yan
- Han, Gencheng
- He, Yuxian
- Zhou, Xiaojun
- Jiang, Shibo
- Sun, Shihui
- Qin, Cheng-Feng
- Zhou, Yusen
- Venue
- Science
- Published
- 2020-09-25
- Volume
- 369
- Issue
- 6511
- Pages
- 1603-1607
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC7574913
- OpenAlex
- W3045870925
- Cited by
- 762
- References
- 30
- Citations by year
- 2026: 20 · 2025: 36 · 2024: 66 · 2023: 82 · 2022: 194 · 2021: 321 · 2020: 42
- FWCI
- 21.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Science (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (82041006, 82041025)
- National Science Fund for Distinguished Young Scholars (81925025)
- National Science and Technology Major Project of China (2018ZX09711003, 2017ZX10304402)
- Beijing Municipal Science and Technology Project (201100001020004)
- National Key Plan for Scientific Research and Development of China (2016YFD0500304, 2016YFD0500306, 2020YFA0707801)
- Innovation Fund for Medical Sciences of the Chinese Academy of Medical Sciences. (2019-I2M-5-049)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS-CoV-2, BALB/c mice, vaccine efficacy, serial passage, N501Y mutation, spike protein receptor-binding domain, interstitial lung disease, aged mice, challenge model, adaptive mutation, viral virulence
- MeSH terms
- Immunogenicity, Vaccine, Betacoronavirus, Angiotensin-Converting Enzyme 2, COVID-19, SARS-CoV-2, COVID-19 Vaccines, Administration, Intranasal, Animals, Disease Models, Animal, Female, Humans, Peptidyl-Dipeptidase A, Lung, Mice, Inbred BALB C, Mice, Transgenic, Mutation, Pneumonia, Viral, Vaccines, Synthetic, Viral Vaccines, Virulence, Lung Diseases, Interstitial, Coronavirus Infections, Mice, Pandemics, High-Throughput Nucleotide Sequencing, Spike Glycoprotein, Coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.